Cambridge, MA-based Myomo (MYO) completes its $5M IPO under SEC Regulation A+. Trading in the company's common stock commences Monday, June 12.
The medical device firm develops orthotics, specifically myoelectric braces, for people with neuromuscular disorders. Its MyoPro line features a myoelectric-controlled upper limb brace designed to improve daily functional activities in patients with a weak or deformed arm.
READ FULL ARTICLE HERE